Review
Open access
Jul 2026
Mitochondrial dysfunction-driven PANoptosis in doxorubicin-induced cardiotoxicity: mechanistic insights and intervention strategies
The aim is to balance the antitumor efficacy of DOX and reduce its cardiac adverse effects, thereby providing a new theoretical basis and potential therapeutic targets for the clinical prevention and treatment of DIC.
Xin-Yu Xue, Xi-Han Liao, Xing Ji et al.
· Frontiers in Pharmacology · 0 citations